Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S23 pseudogene 8 (RPS23P8) is a processed pseudogene in the human genome, corresponding to the ribosomal protein S23 gene but lacking coding capacity and functional protein product[2][8][11]. This pseudogene is one of many non-functional copies of ribosomal protein genes present in the human genome, arising from retrotransposition or duplication events[11]. RPS23P8 does not encode an active protein and has no established role in biological processes, disease association, or as a therapeutic target. It is included in genome annotation for completeness, but does not directly contribute to cellular or physiological function. Its main relevance is as a genomic feature, not as a drug target, biomarker, or pathway node. RPS23P8 is a pseudogene, meaning it is a defunct copy of a gene with no protein product and no demonstrated biological activity[2][8][11]. It is not considered a target for therapeutics, diagnostics, or research beyond its role in the study of genomic structure and evolution. The functional ribosomal protein is encoded by the RPS23 gene, which is distinct from this pseudogene and does have clear protein synthesis functions[4][7][10], but RPS23P8 itself is not implicated in these roles. There is no evidence of drug interactions, disease association, or therapeutic mechanisms linked to RPS23P8. In summary, RPS23P8 is a non-functional pseudogene, sometimes annotated for genomic research but not relevant as a molecular target or for pharmacological intervention.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S23 pseudogene 8 (RPS23P8).